Centra Health INC
Centra Health INC was paid $5.20M by Medicaid between Jan 2018 and Dec 2024, across 165 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 16% of everything it billed.
LYNCHBURG, VA 24501
Next to other Clinical Medical Laboratory providers in Virginia
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,409 | $196K | |
| 2019 | 60,509 | $419K | |
| 2020 | 60,390 | $798K | |
| 2021 | 84,915 | $1.30M | |
| 2022 | 77,091 | $1.12M | |
| 2023 | 45,686 | $561K | |
| 2024incomplete | 60,804 | $811K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 16% | 15,393 | 14,192 | $858K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.8% | 9,745 | 9,328 | $456K |
| 80053 | Comprehensive metabolic panel | 5.8% | 38,547 | 35,001 | $303K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.8% | 15,764 | 15,003 | $301K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.6% | 24,637 | 23,268 | $289K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 5.4% | 5,500 | 4,784 | $279K |
| 80061 | Lipid panel | 4.2% | 20,825 | 19,910 | $219K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.2% | 7,423 | 6,977 | $218K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.1% | 7,380 | 6,970 | $213K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.0% | 36,815 | 32,947 | $206K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.2% | 6,000 | 5,640 | $114K |
| 82607 | 1.7% | 8,425 | 8,027 | $91K |
153 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 1.6% | 12,428 | $81K |
| 83970 | 1.5% | 2,607 | $79K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.5% | 12,124 | $76K |
| 82728 | 1.4% | 6,873 | $74K | |
| 84439 | <1% | 7,117 | $51K | |
| 86780 | <1% | 4,497 | $50K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,797 | $49K |
| 86803 | <1% | 4,113 | $44K | |
| 87081 | <1% | 7,676 | $44K | |
| 83550 | <1% | 6,327 | $43K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 349 | $40K |
| 83540 | <1% | 7,667 | $39K | |
| 83880 | <1% | 1,191 | $33K | |
| 80074 | <1% | 920 | $32K | |
| 85027 | <1% | 5,540 | $29K | |
| 87186 | <1% | 4,169 | $29K | |
| 82784 | <1% | 1,447 | $26K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 884 | $26K |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,821 | $24K |
| 87340 | <1% | 3,023 | $23K | |
| 82570 | <1% | 5,592 | $22K | |
| 86003 | <1% | 1,192 | $22K | |
| 84702 | <1% | 2,905 | $22K | |
| 83735 | <1% | 4,475 | $21K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 361 | $21K |
| 84403 | <1% | 904 | $19K | |
| 80076 | <1% | 2,853 | $19K | |
| 87088 | <1% | 2,730 | $18K | |
| 86038 | <1% | 1,659 | $17K | |
| 84481 | <1% | 1,439 | $17K | |
| 87077 | <1% | 2,368 | $16K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 785 | $16K |
| 84152 | <1% | 1,321 | $16K | |
| 80050 | General health panel | <1% | 1,184 | $16K |
| 86320 | <1% | 384 | $16K | |
| 87070 | <1% | 2,440 | $16K | |
| 86140 | <1% | 3,568 | $16K | |
| 82378 | <1% | 1,053 | $15K | |
| 86757 | <1% | 554 | $15K | |
| 86618 | <1% | 1,142 | $15K | |
| 86008 | <1% | 1,093 | $14K | |
| 87807 | <1% | 1,332 | $13K | |
| 87147 | <1% | 2,831 | $13K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 212 | $13K |
| 81001 | <1% | 5,030 | $12K | |
| 83516 | <1% | 1,140 | $11K | |
| 86706 | <1% | 1,551 | $11K | |
| 86704 | <1% | 1,127 | $11K | |
| 80069 | <1% | 1,732 | $11K | |
| 85610 | <1% | 3,366 | $11K | |
| 84550 | <1% | 3,135 | $11K | |
| 84156 | <1% | 3,734 | $11K | |
| 85651 | <1% | 3,155 | $10K | |
| 84146 | <1% | 601 | $10K | |
| 84165 | <1% | 711 | $9K | |
| 83655 | <1% | 874 | $9K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 127 | $9K |
| 87641 | <1% | 238 | $8K | |
| 87205 | <1% | 2,204 | $8K | |
| 86762 | <1% | 1,207 | $7K | |
| 83001 | <1% | 484 | $7K | |
| 80164 | <1% | 735 | $7K | |
| 84153 | <1% | 535 | $7K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 211 | $7K |
| 83690 | <1% | 1,342 | $7K | |
| 83615 | <1% | 1,514 | $7K | |
| 80361 | <1% | 466 | $7K | |
| 82043 | <1% | 2,094 | $7K | |
| 86431 | <1% | 1,332 | $6K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 159 | $6K |
| 82785 | <1% | 445 | $6K | |
| 81382 | <1% | 40 | $6K | |
| 80197 | <1% | 630 | $5K | |
| 84100 | <1% | 1,591 | $5K | |
| 87522 | Neg quan hep c or qual rna | <1% | 201 | $5K |
| 86592 | <1% | 1,875 | $4K | |
| 87536 | <1% | 97 | $4K | |
| 86850 | <1% | 1,282 | $4K | |
| 82533 | <1% | 246 | $4K | |
| 83525 | <1% | 427 | $3K | |
| 86666 | <1% | 356 | $3K | |
| 85652 | <1% | 1,261 | $3K | |
| 83520 | <1% | 264 | $3K | |
| 82746 | <1% | 369 | $3K | |
| 86900 | <1% | 1,118 | $3K | |
| 86300 | <1% | 415 | $3K | |
| 82550 | <1% | 512 | $3K | |
| 82105 | <1% | 263 | $3K | |
| 84425 | <1% | 355 | $2K | |
| 83020 | <1% | 234 | $2K | |
| 86901 | <1% | 1,140 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 31 | $2K |
| 80349 | <1% | 214 | $2K | |
| 83021 | <1% | 167 | $2K | |
| 87184 | <1% | 547 | $2K | |
| 86364 | <1% | 215 | $2K | |
| 86376 | <1% | 145 | $2K | |
| 88346 | <1% | 28 | $2K | |
| 89055 | <1% | 502 | $2K | |
| 86200 | <1% | 151 | $2K | |
| 86039 | <1% | 211 | $2K | |
| 80047 | <1% | 248 | $2K | |
| 87045 | <1% | 508 | $2K | |
| 86787 | <1% | 259 | $2K | |
| 82670 | <1% | 54 | $1K | |
| 83521 | <1% | 195 | $1K | |
| 83002 | <1% | 81 | $1K | |
| 80178 | <1% | 233 | $1K | |
| 82947 | <1% | 477 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 86 | $1K |
| 85045 | <1% | 321 | $1K | |
| 86361 | <1% | 62 | $1K | |
| 87529 | <1% | 21 | $959.65 | |
| 82150 | <1% | 265 | $935.95 | |
| 87046 | <1% | 507 | $829.05 | |
| 81015 | <1% | 314 | $823.27 | |
| 84466 | <1% | 77 | $767.99 | |
| 87328 | <1% | 53 | $666.23 | |
| 86235 | <1% | 51 | $623.83 | |
| 86160 | <1% | 42 | $612.86 | |
| 82247 | <1% | 134 | $600.19 | |
| 84402 | <1% | 27 | $576.14 | |
| 87329 | <1% | 53 | $566.52 | |
| 83883 | <1% | 83 | $535.22 | |
| 85007 | <1% | 148 | $521.36 | |
| 83921 | <1% | 25 | $483.19 | |
| 85380 | <1% | 61 | $470.82 | |
| 86696 | <1% | 37 | $420.29 | |
| 86480 | <1% | 78 | $405.26 | |
| 83721 | <1% | 60 | $345.89 | |
| 82565 | <1% | 76 | $326.64 | |
| 80348 | <1% | 28 | $310.24 | |
| 83993 | <1% | 15 | $308.17 | |
| 86708 | <1% | 37 | $291.29 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 27 | $290.46 |
| 82248 | <1% | 67 | $284.56 | |
| 83631 | <1% | 14 | $279.73 | |
| 87338 | <1% | 28 | $276.35 | |
| 86677 | <1% | 45 | $243.80 | |
| 83090 | <1% | 15 | $217.71 | |
| 87521 | Neg quan hep c or qual rna | <1% | 15 | $203.28 |
| 86231 | <1% | 24 | $189.84 | |
| 82950 | <1% | 47 | $179.93 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 27 | $178.36 |
| 86800 | <1% | 14 | $172.49 | |
| 87425 | <1% | 18 | $166.86 | |
| 85018 | <1% | 80 | $155.59 | |
| 86695 | <1% | 22 | $152.38 | |
| 80373 | <1% | 12 | $145.11 | |
| 85730 | <1% | 26 | $120.77 | |
| 82272 | <1% | 28 | $100.28 | |
| 86694 | <1% | 23 | $95.68 | |
| 81003 | <1% | 19 | $38.76 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Centra Health INC | Lynchburg, VA | $78.57M |
| Centra Medical Group, LLC | Lynchburg, VA | $60.16M |
| Centra Health INC | Lynchburg, VA | $18.47M |
| Centra Health INC | Lynchburg, VA | $2.82M |
| Centra Health INC | Lynchburg, VA | $2.35M |
| Centra Health INC | Lynchburg, VA | $2.04M |
| Centra Health INC | Lynchburg, VA | $1.59M |
| Centra Health INC | Lynchburg, VA | $205K |
| Centra Health, INC. | Lynchburg, VA | $13K |
| Centra Medical Group, LLC | Lynchburg, VA | $12K |
| Centra Health INC | Lynchburg, VA | $7K |
| Centra Medical Group, LLC | Lynchburg, VA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.